InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,554.13
(
1.07%
)
US TECH 100
18,718.00
(
2.03%
)
Dow Jones
40,861.71
(
0.31%
)
Brent Oil
70.52
(
1.42%
)
Bitcoin
57,418.31
(
-0.43%
)
Post# of 704019
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

jeffsaxx

Send PM Follow Ignore
Followers 14
Posts 1957
Boards Moderated 0
Alias Born 06/26/2003

jeffsaxx

Re: None

Wednesday, 12/07/2005 5:58:01 PM

Wednesday, December 07, 2005 5:58:01 PM

Post# of 704019
ELN -- president of the company said in an interview with the London Times published today ... "IT IS INCONCEIVABLE" (his words not mine) that the FDA will not approve re-introduction of tysabri because in his opinion the data provided for resubmittal was much better than the original data upon which the FDA had previously granted approval of tysabri --- maybe that accounts for the run-up today
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up